Specifically, higher levels of CD19 on transitional B cells, CD20 on IgD− CD24− B cells, CD28 on CD39+ secreting Treg, HLA-DR+ CD8 bright AC, and IgD on unswitched memory B cells were associated with a decreased risk of BC. This evidence concerns the gene CD8A and breast cancer.